Saroj Verma
Overview
Explore the profile of Saroj Verma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lobe M, Verma S, Patil V, Iyer M
Eur J Med Chem
. 2025 Feb;
287:117205.
PMID: 39893986
Myriad signaling pathways are implicated in neuropsychiatric disorders, yet many mechanisms are unknown and current treatment options are limited. The intriguing dynorphin/kappa opioid receptor (KOR) system that is widely distributed...
2.
Agarwal U, Verma S, Tonk R
Bioorg Med Chem Lett
. 2024 Aug;
111:129912.
PMID: 39089526
Alzheimer's disease (AD) presents a growing global health concern. In recent decades, natural and synthetic chromenone have emerged as promising drug candidates due to their multi-target potential. Natural chromenone, quercetin,...
3.
Kumar S, Lata S, Verma S, Anupriya
Indian J Psychol Med
. 2024 Jul;
46(4):298-304.
PMID: 39056030
Background: Suicide is common among persons with physical disabilities as they face several physical, social, psychological, and economic problems. They are at risk for suicidal thoughts, behaviors, and death by...
4.
Singhal S, Manikrao Patil V, Verma S, Masand N
Bioorg Chem
. 2024 Mar;
146:107277.
PMID: 38493634
Diabetes mellitus (DM) is one of the largest public health problems worldwide and in the last decades various therapeutic targets have been investigated. For the treatment of type-2 DM (T2DM),...
5.
Patil V, Verma S, Masand N
Eur J Med Chem Rep
. 2023 Jan;
4:100018.
PMID: 36593981
The well-known anti-helminthic drug ivermectin (IVM) has been established as an example of drug repurposing for the management of SARS-CoV-2 infection. Various study has been done to understand the inhibitory...
6.
Verma S, Masand N, Cheke R, Patil V
Curr Top Med Chem
. 2022 Nov;
22(26):2207-2220.
PMID: 36345238
Clinical translation is a challenging step in the development of cancer vaccines and is found to be related to the complex nature of cancer immunology. Vaccine-based therapeutic strategies for cancer...
7.
Verma S, Patil V, Gupta M
Drug Discov Today
. 2022 Jul;
27(10):103312.
PMID: 35787481
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoes mutations at a high rate and with frequent genetic reassortment (antigenic drift/shift), leading to variability in targets. The receptor-binding domain (RBD) of...
8.
Kumari R, Ranjan J, Verma S, Asthana H
Indian J Psychol Med
. 2022 Jun;
44(2):167-172.
PMID: 35655969
Background: The Affiliate Stigma Scale (ASS) is a widely used tool to measure affiliate stigma in the caregivers of individuals with various types of mental illnesses. However, the Hindi adaptation...
9.
Dewaker V, Srivastava P, Verma S, Srivastava A, Prabhakar Y
J Biomol Struct Dyn
. 2021 Oct;
40(24):13432-13455.
PMID: 34662251
Designing an inhibitor having strong affinity in the active site pocket is the cherished goal of structure based drug designing. To achieve this, it is considerably important to predict which...
10.
Patil V, Masand N, Verma S, Masand V
Chem Biol Drug Des
. 2021 Sep;
98(5):943-953.
PMID: 34519163
In the design and discovery of anticancer drugs, various natural heterocyclic scaffolds have attracted considerable interest as privileged structures. For rational drug design, some of the natural scaffolds such as...